Baebies' Series B - II Round

Baebies raised a round of funding on October 31, 2017.

Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. I…

Articles about Baebies' Series B - II Round: